---
title: "HANG TAI YUE GP released its interim results, with a loss attributable to shareholders of HKD 19.236 million, a year-on-year decrease of 18.74%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255250913.md"
description: "According to the Zhitong Finance APP, HANG TAI YUE GP released its interim results for the six months ending June 30, 2025, reporting revenue of HKD 34.502 million, a year-on-year decrease of 9.37%; the loss attributable to the company's owners was HKD 19.236 million, a year-on-year decrease of 18.74%; the loss per share was HKD 0.037"
datetime: "2025-08-29T16:32:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255250913.md)
  - [en](https://longbridge.com/en/news/255250913.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255250913.md)
generator: "portal-rs"
---

# HANG TAI YUE GP released its interim results, with a loss attributable to shareholders of HKD 19.236 million, a year-on-year decrease of 18.74%

According to the Zhitong Finance APP, HANG TAI YUE GP (08081) released its interim results for the six months ending June 30, 2025, reporting revenue of HKD 34.502 million, a year-on-year decrease of 9.37%; the loss attributable to shareholders was HKD 19.236 million, a year-on-year decrease of 18.74%; the loss per share was HKD 0.037

### Related Stocks

- [08081.HK](https://longbridge.com/en/quote/08081.HK.md)

## Related News & Research

- [China Tianrui Cement Sets EGM Record Date Amid Planned Auditor Change](https://longbridge.com/en/news/298714010.md)
- [Embodied AI startup PHYMI raises nearly US$100 million in seed funding](https://longbridge.com/en/news/298548201.md)
- [Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer](https://longbridge.com/en/news/298831859.md)
- [Aignostics lance PathoSearch, un moteur de recherche visuel dédié aux cas pathologiques](https://longbridge.com/en/news/298827083.md)
- [China Oral Industry Group forms Shenzhen synthetic biology JV with Future Century, takes 51% stake](https://longbridge.com/en/news/298570917.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**